These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223 [TBL] [Abstract][Full Text] [Related]
11. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Monplaisir N; Merault G; Poyart C; Rhoda MD; Craescu C; Vidaud M; Galacteros F; Blouquit Y; Rosa J Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9363-7. PubMed ID: 3467311 [TBL] [Abstract][Full Text] [Related]
12. Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed. Thangaswamy S; Branch CA; Ambadipudi K; Acharya SA Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680105 [TBL] [Abstract][Full Text] [Related]
13. New therapies in sickle cell disease. Vichinsky E Lancet; 2002 Aug; 360(9333):629-31. PubMed ID: 12241949 [TBL] [Abstract][Full Text] [Related]
14. Knockout-transgenic mouse model of sickle cell disease. Ryan TM; Ciavatta DJ; Townes TM Science; 1997 Oct; 278(5339):873-6. PubMed ID: 9346487 [TBL] [Abstract][Full Text] [Related]